AJU IB Investment
VC
INVESTOR TYPE
Active
STATUS
19
PROFESSIONALS
47
INVESTMENTS
26
PORTFOLIO
17
EXITS
Description
Founded in 1974, AJU IB Investment is a venture capital firm based in Seoul, South Korea. The firm operates as Solasta Ventures in the United States of America with offices in Boston, Massachusetts, and San Francisco, California.
Website
Formerly Known As
Korea Technology Development Corporation
Investor Status
Actively Seeking New Investments
Year Founded
1974
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
PE/Buyout
Primary Office
- 201, Teheran-ro
- Gangnam-gu
- Seoul
- South Korea
+82 00-0000-0000
AJU IB Investment Investments (47)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Sparkplus | 03-Dec-2019 | Early Stage VC | 000.00 | Real Estate Services (B2C) | Generating Revenue | |
| 00000000 | 06-Nov-2019 | 00000 00000 | 00.00 | Media and Information Services (B2B) | Generating Revenue | |
| 0000000 | 14-Oct-2019 | 00000 00000 | 0000 | Biotechnology | Pre-Clinical Trials | 0000 0000000 |
| 000000000 00000000 | 24-Sep-2019 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | |
| 00000 000000000000 | 22-Aug-2019 | 00000 00000 | 0000 | Connectivity Products | Generating Revenue | 0000000 0000 |
| 0000000 0000000000 | 16-Jul-2019 | 00000 00000 | 0000 | Drug Discovery | Pre-Clinical Trials | 00000 0000 |
| 0000 000000000000 | 18-Jun-2019 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - General | |
| 0000 | 07-Mar-2019 | 00000 00000 | 000.00 | Decision/Risk Analysis | Product Development | |
| Dano | 01-Feb-2019 | Later Stage VC | 00.000 | Other Services (B2C Non-Financial) | Generating Revenue | |
| Kymera | 13-Nov-2018 | Early Stage VC | 0000 | Biotechnology | Generating Revenue |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore AJU IB Investment’s full profile, request a free trial.
AJU IB Investment Exits (17)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| RAPT Therapeutics | 01-Nov-2019 | IPO | 0000 | Completed |
|
| 00000 000000000 | 27-Sep-2018 | 000 | 0000 | Completed |
|
| 000000000 00000000 | 20-Sep-2018 | 000000 0000000000 | 000.00 | Completed |
|
| 00000 0000 0000000 | 21-Jun-2018 | 000 | 0000 | Completed |
|
| 0000000 | 09-Nov-2017 | 000 | 00000 | Completed |
|
| 00000 | 03-Nov-2017 | 000 | 00000 | Completed |
|
| 0000000 0000000000 | 29-Jun-2017 | 000 | 000.00 | Completed |
|
| 00 000000000000 | 17-May-2017 | 000 | 00000 | Completed |
|
| Selecta Biosciences | 22-Jun-2016 | IPO | 0000 | Completed |
|
| Clearside Biomedical | 02-Jun-2016 | IPO | 000.00 | Completed |
|
AJU IB Investment Team (24)
4 Former Team Members
You’re viewing 5 of 24 team members. Get the full list »AJU IB Investment Co-Investors (111)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| Cormorant Asset Management | 3 | 0 | 0 |
| Hatteras Venture Partners | 0 | 0 | 0 |
| Celgene | 0 | ||
| Morningside Group | 0 | 0 | |
| Qiming Venture Partners | 0 | 0 |